Hi Exalted - I think this is mainly due to the IP Big Pharma nature of the IHL and BOT businesses that the MC is quite stable. Medical IP is Medical IP - has enormous value and a good guide to global appetite for intellectual property are the IP patent apps and ventures Big Pharma is undertaking. I posted a while ago a list of players and their growing interests. Its massive. (Also helps when IHL is undervalued to peers and with a much better model IMO than just distribution or cultivation.
What I am confident in, is the early growth phase of the Cannabis medicinal industry. This is proving up globally and IP is the key - aka Cochlear. A solution to global health issues, or even an improvement in treating them isn't a "bottle of CBD" play - it is a different beast. I think the market understands this.
A good example is PCK and their med app - all IP. Lots of floundering players in that sector but this company does very well - huge IP as it has a product that is different and it works. If you own a medical solution - its a killer. It doesn't really matter whether it is CBD as such - it is whether it works and whether it is unique.
- Forums
- ASX - By Stock
- IHL
- Share your ideas and thoughts.
Share your ideas and thoughts., page-9
-
- There are more pages in this discussion • 682 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IHL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online